A University of Arizona Health Sciences study of COVID-19 vaccine effectiveness and immunity among frontline workers, families and children has received $22 million from the U.S. Centers for Disease Control and Prevention to continue the research for another year.

CDC funding will allow research on COVID-19 immunity and vaccine effectiveness to continue as new variants emerge.

The new BA-5 variant of the coronavirus is now the dominant strain in Arizona, where it is responsible for slightly less than 60% of new cases.

Margie Balfour, MD, PhD, associate professor of psychiatry in the College of Medicine – Tucson, co-authors a story on the upcoming “soft launch” of a new emergency number for behavioral health emergencies.

A commonly prescribed cancer and arthritis drug sometimes used as an oral abortifacient is facing prescription roadblocks in wake of the Supreme Court's overturning of Roe v Wade.

Esther M. Sternberg, MD, professor of medicine in the College of Medicine – Tucson, will be featured on the July 20 edition of Medical Matters Weekly, produced by Southwestern Vermont Health Care.

Patricia Lebensohn, MD, medical director of the Commitment to Underserved People Program, shared her experiences in a recent issue of The New Physician.

Pancreatic cancer is the most lethal of cancers, with an overall five-year survival rate of approximately 7%.

Pharmacists and navigators learned how to better relate to Black and Hispanic patients using an education program designed by the Western Region Public Health Training Center in the Mel and Enid Zuckerman College of Public Health.